Anwaar Saeed
Clinical trials sponsored by Anwaar Saeed, explained in plain language.
-
New hope for advanced GI cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two or three drugs (cabozantinib, durvalumab, and possibly tremelimumab) in people with advanced stomach, esophageal, liver, or colorectal cancer that cannot be removed by surgery. The goal is to find the safest dose and see if the treatment can …
Phase: PHASE1, PHASE2 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated May 26, 2026 10:08 UTC
-
Triple-Drug attack aims to shrink untreatable liver tumors
Disease control Recruiting nowThis study tests a new three-drug combination for people with advanced liver cancer that cannot be removed by surgery. The drugs work together to boost the immune system and block cancer growth. About 40 participants who have not had prior systemic therapy will receive the treatm…
Phase: PHASE2 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated May 22, 2026 13:53 UTC